{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:23:39Z","timestamp":1769603019191,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,2,27]],"date-time":"2006-02-27T00:00:00Z","timestamp":1140998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,2,27]],"date-time":"2006-02-27T00:00:00Z","timestamp":1140998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1038\/sj.bmt.1705307","type":"journal-article","created":{"date-parts":[[2006,2,27]],"date-time":"2006-02-27T11:21:05Z","timestamp":1141039265000},"page":"731-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients"],"prefix":"10.1038","volume":"37","author":[{"given":"D","family":"O'Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Perz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Politou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Sana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Narat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Kanfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Olavarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J F","family":"Apperley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Rahemtulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,27]]},"reference":[{"key":"BF1705307_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","volume":"51","author":"RT Greenlee","year":"2001","unstructured":"Greenlee RT, Hill-Harmon MB, Murray T, Thun M . Cancer statistics, 2001. CA Cancer J Clin 2001; 51: 15\u201336.","journal-title":"CA Cancer J Clin"},{"key":"BF1705307_CR2","doi-asserted-by":"crossref","unstructured":"Myeloma Trialists\u2019 Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6663 patients from 27 randomised trials. J Clin Oncol 1998; 16: 3832\u20133842.","DOI":"10.1200\/JCO.1998.16.12.3832"},{"key":"BF1705307_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/bjc.1998.77","volume":"77","author":"A Riccardi","year":"1998","unstructured":"Riccardi A, Mora O, Brugnatelli S, Tinelli C, Spanedda R, De Paoli A et al. Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomised protocol. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer 1998; 77: 485\u2013491.","journal-title":"Br J Cancer"},{"key":"BF1705307_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomised trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BF1705307_CR5","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BF1705307_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1704562","volume":"34","author":"R Alexanian","year":"2004","unstructured":"Alexanian R, Weber D, Delasalle K, Handy B, Champlin R, Giralt S et al. Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant 2004; 34: 229\u2013234.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1046\/j.1365-2141.2001.02976.x","volume":"114","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C, Zangari M et al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol 2001; 114: 600\u2013607.","journal-title":"Br J Haematol"},{"key":"BF1705307_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1365-2141.1999.01133.x","volume":"104","author":"D Gupta","year":"1999","unstructured":"Gupta D, Bybee A, Cooke F, Giles C, Davis JG, MCDonald C et al. CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome. Br J Haematol 1999; 104: 166\u2013177.","journal-title":"Br J Haematol"},{"key":"BF1705307_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blade","year":"1998","unstructured":"Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. Br J Haematol 1998; 102: 1115\u20131123.","journal-title":"Br J Haematol"},{"key":"BF1705307_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0037-1963(01)90013-7","volume":"38","author":"B Bjorkstrand","year":"2001","unstructured":"Bjorkstrand B . European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma. Semin Hematol 2001; 38: 219\u2013225.","journal-title":"Semin Hematol"},{"key":"BF1705307_CR11","first-page":"844","volume":"84","author":"I Majolino","year":"1999","unstructured":"Majolino I, Vignetti M, Meloni G, Vegna ML, Scime R, Tringali S et al. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Haematologica 1999; 84: 844\u2013852.","journal-title":"Haematologica"},{"key":"BF1705307_CR12","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1200\/JCO.2004.06.144","volume":"22","author":"C Morris","year":"2004","unstructured":"Morris C, Iacobelli S, Brand R, Bjorkstrand B, Drake M, Niederwieser D et al. Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. J Clin Oncol 2004; 22: 1674\u20131681.","journal-title":"J Clin Oncol"},{"key":"BF1705307_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1701062","volume":"21","author":"A Alegre","year":"1998","unstructured":"Alegre A, Diaz-Mediavilla J, San-Miguel J, Martinez R, GarciaLarana J, Sureda A et al. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM and PETHEMA. Bone Marrow Transplant 1998; 21: 133\u2013140.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1365-2141.1994.tb06731.x","volume":"87","author":"MA Dimopoulos","year":"1994","unstructured":"Dimopoulos MA, Hester J, Huh Y, Champlin R, Alexanian R . Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma. Br J Haematol 1994; 87: 730\u2013734.","journal-title":"Br J Haematol"},{"key":"BF1705307_CR15","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1200\/JCO.1999.17.7.2173","volume":"17","author":"DH Vesole","year":"1999","unstructured":"Vesole DH, Crowley JJ, Catchatourian R, Stiff PJ, Johnson DB, Cromer J et al. High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial. J Clin Oncol 1999; 17: 2173\u20132179.","journal-title":"J Clin Oncol"},{"key":"BF1705307_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bmt.1703717","volume":"30","author":"S Singhal","year":"2002","unstructured":"Singhal S, Powles R, Sirohi B, Treleaven J, Kulkami S, Mehta J et al. Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma. Bone Marrow Transplant 2002; 30: 673\u2013679.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bmt.1702640","volume":"26","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE et al. Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplant 2000; 26: 979\u2013983.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bmt.1704728","volume":"35","author":"M Krejci","year":"2005","unstructured":"Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L et al. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplant 2005; 35: 159\u2013164.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2141.2004.05120.x","volume":"126","author":"MH Bakkus","year":"2004","unstructured":"Bakkus MH, Bouko Y, Samson D, Apperley JF, Thielemans K, Van Camp B et al. Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma. Br J Haematol 2004; 126: 665\u2013674.","journal-title":"Br J Haematol"},{"key":"BF1705307_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.bmt.1704313","volume":"33","author":"E Nadal","year":"2004","unstructured":"Nadal E, Gine E, Blade J, Esteve J, Rosinol L, Fernandez-Aviles F et al. High-dose therapy\/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Bone Marrow Transplant 2004; 33: 61\u201364.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.bmt.1704192","volume":"32","author":"H Einsele","year":"2003","unstructured":"Einsele H, Bamberg M, Budach W, Schmidberger H, Hess CF, Wormann B et al. A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma. Bone Marrow Transplant 2003; 32: 593\u2013599.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","volume":"93","author":"DS Siegel","year":"1999","unstructured":"Siegel DS, Desikan KR, Mehta J, Singhal S, Fassas A, Munshi N et al. Age is not a prognostic variable with autotransplants for multiple myeloma. Blood 1999; 93: 51\u201354.","journal-title":"Blood"},{"key":"BF1705307_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bmt.1702188","volume":"25","author":"B Sirohi","year":"2000","unstructured":"Sirohi B, Powles R, Treleaven J, Mainwaring P, Kulkarni S, Pandha H et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant 2000; 25: 533\u2013539.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bmt.1704288","volume":"32","author":"DE Reece","year":"2003","unstructured":"Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK et al. Autologous stem cell transplantation in multiple myeloma patients <60 vs \u2a7e60 years of age. Bone Marrow Transplant 2003; 32: 1135\u20131143.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705307_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2141.2002.03231.x","volume":"116","author":"G Tricot","year":"2002","unstructured":"Tricot G, Spencer T, Sawyer J, Spoon D, Desikan R, Fassas A et al. Predicting long-term (> or =5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants. Br J Haematol 2002; 116: 211\u2013217.","journal-title":"Br J Haematol"},{"key":"BF1705307_CR26","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood.V92.9.3131","volume":"92","author":"JP Fermand","year":"1998","unstructured":"Fermand JP, Ravaud P, Chevret S, Divine M, Lebond V, Belanger C et al. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood 1998; 92: 3131\u20133136.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705307","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:09:56Z","timestamp":1648080596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,27]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,4,1]]}},"alternative-id":["BF1705307"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705307","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,27]]},"assertion":[{"value":"28 February 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}